Table 1.
Clinicopathologic characteristics of 103 lung adenocarcinoma patients.
| Characteristics | Number of patients | % |
|---|---|---|
| Age, years | ||
| ≥60 | 58 | 56.3 |
| <60 | 45 | 43.7 |
| Sex | ||
| Male | 40 | 38.8 |
| Female | 63 | 61.2 |
| Smoking status | ||
| Never | 60 | 58.3 |
| Ever | 43 | 41.7 |
| Tumor location | ||
| Upper lobe | 53 | 52.4 |
| Nonupper lobe | 60 | 47.6 |
| Histology grade | ||
| Well-moderate | 88 | 85.4 |
| Poor | 15 | 14.6 |
| T stage | ||
| T1-2 | 86 | 83.5 |
| T3-4 | 17 | 16.5 |
| N stage | ||
| N0-1 | 75 | 72.8 |
| N2 | 28 | 27.2 |
| TNM stage | ||
| I-II | 63 | 61.2 |
| III | 40 | 38.8 |
| Adjuvant therapy | ||
| Yes | 80 | 77.7 |
| No | 23 | 22.3 |
| CEA | ||
| ≥5.2 ng/mL | 36 | 40.0 |
| <5.2 ng/mL | 67 | 60.0 |
| Hb | ||
| ≥115 g/L | 92 | 89.3 |
| <115 g/L | 11 | 10.7 |
| PLR | ||
| ≥120 | 51 | 49.5 |
| <120 | 52 | 50.5 |
CEA, carcinoembryonic antigen; Hb, hemoglobin; PLR, platelet to lymphocyte ratio.